Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
about
Circulating serum free light chains as predictive markers of AIDS-related lymphoma.Immune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaSerum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis.Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosisDifferential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosusSerum free light chains and the risk of ESRD and death in CKDDistribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome Patients.Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationFree light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma.Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease.Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review.Human neonatal thymectomy induces altered B-cell responses and auto-reactivity.Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma.The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease.The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome.Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion.Urinary free light chains may help to identify infection in patients with elevated systemic inflammation due to rheumatic disease.An unusual case of chronic lymphocytic leukemia, multiple myeloma and cardiac amyloidosisPolyclonal free light chains: a biomarker of inflammatory disease or treatment target?Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant.Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification.Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients.Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps.Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
P2860
Q33710567-C72EA92F-8CC9-4BC2-885B-AE5CC5664681Q33887336-13F48879-78E0-4D76-A083-A662A27A432CQ33988217-DB7F0EC7-AA8D-480C-B299-47C19795E027Q34743817-46AE7BBE-2BEE-4069-81DE-378AE1820A55Q34806379-BEC1C049-B912-41AF-A96C-7A5280D9F744Q34866311-83356EEE-43F7-4BD7-9C7B-B97F90463343Q35210847-9E516EEA-2306-4997-8278-7888B7B438B8Q35212377-D0026108-A2AE-4C34-8728-DF08EE59DD18Q35372594-B3385CAB-122D-4FDD-94DC-D7A8990FD780Q35577284-2FA080CF-590D-4CD3-B139-F850C7C1B458Q35664565-BD2A8906-7C89-4732-8E20-5CCAD365DB52Q35673732-4BDB468E-9604-48F2-B439-001425F19290Q35786726-D9EB0ACF-5E1C-439B-818E-3CC613F6CBA9Q35918672-234749E2-3633-41EE-A438-35AF7FD98DC7Q36513041-CDB3BABF-F056-488F-ACDC-1C2C825E4845Q36748985-DDDB164B-5639-4014-9704-16B63FAB0A66Q36973329-8D23E5FB-3AB5-46F8-AA85-A3B5CD114497Q37009888-2682DD06-BCBD-44A1-BBF8-A61289630C76Q37350904-CC5E60DA-1C18-4528-8316-5B57C5CCE23DQ37627843-C958321F-4F2A-4EF2-8761-5D3DAF119A95Q37780706-A6DDBA86-57FA-4BCE-9318-6313189B28EFQ37821496-68AF8F94-0EB8-41FD-B2F8-50F8FD6CBA05Q38010146-457429B6-3C44-4AD6-AE72-FB2A1FEE4A7DQ38686764-8D9C76E8-8463-4BFD-B5D0-65FB686A8CFAQ39140382-767DC323-2BB2-473C-A695-AAE99752392DQ39297229-379E27B1-E64C-4CD5-8014-42456271272FQ39691687-849FD759-B198-4F90-89E1-329D5771BA99Q40171169-05532171-AFDB-4AA5-B5AC-225F347648A1Q40326976-15CC42F6-B83D-411E-9698-05F36CA0B551Q42375446-F9A85CD8-67C5-4B71-8076-5BA8ED775E54Q43167257-58FD2323-5EE3-45AB-9851-9FCF84FBA90FQ44314941-38A392E3-C051-4FAE-B7BD-0F1B2CA848F2Q44803128-55233E17-4D7D-4E33-B4F9-6A64615E4F9FQ45269184-AE4F6F97-F318-49E7-AD80-A640F582019FQ48897306-BFB655E2-FC55-4E0F-809B-CA832F5B2330Q50980453-F4EFD67C-31A5-45C9-9581-7671E7FD2177Q51075846-0B2FDCE5-BB87-4015-8DB0-97A0E391410AQ53015681-66C2C390-08D1-49DB-B1E4-397FEB5A9297Q53158931-955628A7-B88D-4778-8818-943C2F8E7DAFQ53602479-CB06BEA6-9750-4583-9F5A-86203F32019F
P2860
Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@ast
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@en
type
label
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@ast
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@en
prefLabel
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@ast
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@en
P2093
P2860
P356
P1476
Serum immunoglobulin free ligh ...... nd primary Sjogren's syndrome.
@en
P2093
Aucouturier F
Cayuela JM
Gottenberg JE
Mariette X
P2860
P356
10.1136/ARD.2006.052159
P407
P577
2006-03-28T00:00:00Z